tiprankstipranks
Salarius Pharmaceuticals Inc (SLRX)
NASDAQ:SLRX

Salarius Pharmaceuticals (SLRX) Financial Statements

469 Followers

Salarius Pharmaceuticals Financial Overview

Salarius Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-21.718; its P/E ratio is -0.09; Salarius Pharmaceuticals is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-53.60. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.72M$ -881.80K$ -2.44M$ -3.88M$ -5.42M
EBITDA$ -1.71M$ -880.69K$ -2.44M$ -3.88M$ -5.42M
Net Income Common Stockholders$ -1.72M$ -881.80K$ -2.44M$ -3.88M$ -5.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.37M$ 5.90M$ 7.58M$ 11.54M$ 9.27M
Total Assets$ 4.88M$ 6.59M$ 8.40M$ 12.03M$ 10.06M
Total Debt$ 100.00K$ 300.00K$ 500.00K$ 0.00$ 0.00
Net Debt$ -4.27M$ -5.60M$ -7.08M$ -11.54M$ -9.27M
Total Liabilities$ 1.23M$ 1.30M$ 2.32M$ 3.64M$ 4.50M
Stockholders Equity$ 3.65M$ 5.29M$ 6.08M$ 8.41M$ 5.56M
Cash Flow-
Free Cash Flow$ -1.35M$ -1.51M$ -3.75M$ -4.42M$ -3.15M
Operating Cash Flow$ -1.35M$ -1.51M$ -3.75M$ -4.42M$ -3.15M
Investing Cash Flow-----
Financing Cash Flow$ -172.75K$ -169.45K$ -211.83K$ 6.68M$ 336.68K
Currency in USD

Salarius Pharmaceuticals Earnings and Revenue History

Salarius Pharmaceuticals Debt to Assets

Salarius Pharmaceuticals Cash Flow

Salarius Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis